Related Experiment Video
Updated: Aug 10, 2026
10:39
In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
DOCK8 regulates signal transduction events to control immunity
Conor J Kearney1,2, Katrina L Randall3,4, Jane Oliaro1,2
1Immune Defence Laboratory, Cancer Immunology Division, The Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
Cellular & Molecular Immunology
|April 4, 2017
Summary
DOCK8 deficiency causes combined immunodeficiency, leading to infections and cancer. Recent research highlights DOCK8
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Autosomal recessive hyper immunoglobulin E syndrome (AR-HIES), or DOCK8 deficiency, results from genetic mutations in the DOCK8 gene.
- DOCK8 deficiency leads to combined immunodeficiency disease (CID), characterized by recurrent infections and increased malignancy risk.
- DOCK8 is crucial for lymphocyte function, impacting innate and adaptive immunity.
Purpose of the Study:
- To summarize recent advances in understanding DOCK8 function in immune responses.
- To highlight DOCK8's emerging role as a signaling intermediate.
Main Methods:
- Review of recent scientific literature on DOCK8 function.
- Analysis of DOCK8's role in lymphocyte survival, migration, and immune synapse formation.
- Investigation of DOCK8's involvement in signal transduction pathways regulating immune cell activity.
Main Results:
- DOCK8 is essential for lymphocyte survival, migration, and immune synapse formation, impacting pathogen control.
- DOCK8 plays a critical role in regulating signal transduction, transcriptional activity, and cytokine production in immune cells.
- Emerging evidence points to DOCK8 as a key signaling intermediate promoting immune responses.
Conclusions:
- DOCK8 is vital for effective immune responses, regulating multiple aspects of lymphocyte function.
- Understanding DOCK8's signaling role is crucial for developing therapies for DOCK8 deficiency and related immunodeficiencies.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...